If GLP-1 isn't right for you, we'll tell you
They also cannot state compounded drugs use the same active ingredient as the FDA-approved drugs or that compounded drugs are clinically proven to produce results for the patient. Several days following this announcement, Sources Novo Nordisk expands US patient access to FDA-approved semaglutide medicines through Hims & Hers in response to a shift in their US GLP-1 business model
Patients who push through the first four to eight weeks of treatment, with appropriate management of their symptoms, typically find that side effects improve substantially even as the dose continues to increase
Most members come to us from Ro, Mochi, TrimRx, or Hims here's what's different
We Take Care of the Rest Once your customers sign up, theyre in good hands
What is the Maximus microdosing option